Completed PHASE4 INTERVENTIONAL 3-arm NCT02565212

Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis

Istanbul Gaziosmanpasa Taksim Research and Training Hospital,

Sponsor: Istanbul Training and Research Hospital

Interventions Montelukast,mometazon froat

Updated 6 times since 2017 Last updated: Sep 29, 2015 Started: May 31, 2014 Primary completion: Oct 31, 2014 Completion: Oct 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02565212, this PHASE4 trial focuses on Allergic Rhinitis and remains completed. Sponsored by Istanbul Training and Research Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istanbul Training and Research Hospital

Data source: Istanbul Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.